Return to search

Shore Capital Partners recaps Specialdocs Consultants

Shore Capital Partners said Tuesday that it has completed the recapitalization of Specialdocs Consultants LLC. Financial terms weren’t announced. Highland Park, Illinois-based Specialdocs provides consulting services to physicians transitioning from traditional medical practices to personalized medicine models, also known as “membership” or “concierge” medicine.


CHICAGO–(BUSINESS WIRE)–Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has completed the recapitalization of Specialdocs Consultants, LLC (“Specialdocs” or the “Company”). Specialdocs provides nationwide consulting services to physicians transitioning from traditional medical practices to independent, custom-designed personalized medicine models, also known as “membership” or “concierge” medicine. In addition to initial transition services, the Company provides continuing post-transition support to physicians including patient communication, accounting and membership fee processing, patient outreach and marketing programs, and ongoing staff and physician training.

Shore has partnered with Roberta Greenspan, the founder of Specialdocs, and Michael Friedlander, a Principal with the Company. Roberta, who has 40 years of professional health care experience in both hospital and private practice settings, started Specialdocs in 2002. Roberta developed Specialdocs with the concept of bringing back patient-focused, high quality medical care for physicians and patients alike. She established one of the biggest players in the industry, and has provided services to almost 150 physicians in 30 states. Michael joined Specialdocs full-time in 2007 and brings to the team over four decades of business experience in financial planning, marketing and risk management evaluation. He plays a key role in identifying new physician clients. Shore is enthusiastic about the opportunity to continue to grow Specialdocs’ physician client base and expand the Company’s service offerings.
“We are thrilled to partner with Roberta, Michael and the incredibly talented and passionate Specialdocs team. We look forward to building a leading, nationwide personalized medicine consulting company, while continuing to provide the highest quality, personalized services to our physician clients and their patient members,” said Mike Cooper, Partner at Shore Capital and Chairman of Specialdocs.
Roberta Greenspan commented, “We’re very excited about our partnership with Shore Capital. They share our passion for personalized medicine and I believe they will add great value to Specialdocs and our physician clients. Shore has impressive experience and successes in healthcare investing, along with an understanding of our special culture and the uniqueness of the concierge medicine space.”
In a 2014 survey by the Physicians Foundation, 81% of physicians described themselves as overextended or at full capacity.1 As a result of limited physician bandwidth, patients typically experience longer waits, shortened appointments, reduced provider engagement and reactive care. The personalized membership medicine model helps alleviate these issues for the physician and patient with longer appointments, more personal relationships, same or next-day appointments and a focus on preventative care and wellness. To meet growing demand, Shore plans to invest in additional team members, IT infrastructure and new service offerings.
This investment represents the fifth platform investment out of Shore Capital Partners Fund I, L.P., a $112.5 million investment vehicle raised in May 2014.
About Shore Capital
Shore Capital is a Chicago-based private equity firm focused exclusively on microcap healthcare investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has approximately $150 million of equity capital under management through various investment vehicles including Shore Capital Partners Fund I, L.P. with $112.5 million of capital commitments.